Literature DB >> 26757361

The Involvement of Splicing Factor hnRNP A1 in UVB-induced Alternative Splicing of hdm2.

Jianguo Feng1,2, Li Li1, Lingying Tong2, Liling Tang1, Shiyong Wu2.   

Abstract

Human homolog double minute 2 (hdm2), an oncoprotein, which binds to tumor suppressor p53 to facilitate its degradation, has been known to contribute to tumorigenesis. Its splicing variants are reported to be highly expressed in many cancers and can be induced by ultraviolet B light (UVB). However, the mechanisms of how UVB radiation induces hdm2 alternative splicing still remain unclear. In this study, we investigated the roles of two common splicing factors, heterogeneous nuclear ribonucleoproteins (hnRNP) A1 and serine/arginine-rich splicing factor 1 (SRSF1), in regulating UVB-induced hdm2 splicing. Our study indicated that while the expression of both hnRNP A1 and SRSF1 are induced, only hnRNP A1 is involved in hdm2 alternative splicing upon UVB irradiation. Overexpression of hnRNP A1 resulted in decrease of full-length hdm2 (hdm2-FL) and increase of hdm2B, one of hdm2 alternate-splicing forms; while down-regulated hnRNP A1 expression led to the decrease of the hdm2-FL and hdm2B in HaCaT cells. Protein-mRNA binding assay confirmed that UVB irradiation could increase the binding of hnRNP A1 to hdm2 pre-mRNA. In conclusion, we elucidated that UVB induces alternative splicing of hdm2 by increasing the expression and the binding of hnRNP A1 to hdm2 full-length mRNA.
© 2016 The American Society of Photobiology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26757361      PMCID: PMC4940332          DOI: 10.1111/php.12564

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  31 in total

1.  Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.

Authors:  P H Kussie; S Gorina; V Marechal; B Elenbaas; J Moreau; A J Levine; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

2.  Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.

Authors:  R Honda; H Yasuda
Journal:  Oncogene       Date:  2000-03-09       Impact factor: 9.867

3.  Inflammation and p53: A Tale of Two Stresses.

Authors:  Andrei V Gudkov; Katerina V Gurova; Elena A Komarova
Journal:  Genes Cancer       Date:  2011-04

Review 4.  Regulation of splicing by SR proteins and SR protein-specific kinases.

Authors:  Zhihong Zhou; Xiang-Dong Fu
Journal:  Chromosoma       Date:  2013-03-24       Impact factor: 4.316

5.  Conserved sequences in the final intron of MDM2 are essential for the regulation of alternative splicing of MDM2 in response to stress.

Authors:  Ravi K Singh; Aixa Tapia-Santos; Thomas W Bebee; Dawn S Chandler
Journal:  Exp Cell Res       Date:  2009-07-21       Impact factor: 3.905

Review 6.  Alternative splicing and biological heterogeneity in prostate cancer.

Authors:  Prabhakar Rajan; David J Elliott; Craig N Robson; Hing Y Leung
Journal:  Nat Rev Urol       Date:  2009-08       Impact factor: 14.432

7.  A novel role for the proteasomal chaperone PSMD9 and hnRNPA1 in enhancing IκBα degradation and NF-κB activation - functional relevance of predicted PDZ domain-motif interaction.

Authors:  Indrajit Sahu; Nikhil Sangith; Manoj Ramteke; Rucha Gadre; Prasanna Venkatraman
Journal:  FEBS J       Date:  2014-04-30       Impact factor: 5.542

8.  HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.

Authors:  Rong Guo; Yong Li; Jinying Ning; Dan Sun; Lianjun Lin; Xinmin Liu
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

9.  The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation.

Authors:  Olga Anczuków; Avi Z Rosenberg; Martin Akerman; Shipra Das; Lixing Zhan; Rotem Karni; Senthil K Muthuswamy; Adrian R Krainer
Journal:  Nat Struct Mol Biol       Date:  2012-01-15       Impact factor: 15.369

10.  HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition.

Authors:  Serena Bonomi; Anna di Matteo; Emanuele Buratti; Daphne S Cabianca; Francisco E Baralle; Claudia Ghigna; Giuseppe Biamonti
Journal:  Nucleic Acids Res       Date:  2013-07-17       Impact factor: 16.971

View more
  6 in total

Review 1.  Peptides encoded by noncoding genes: challenges and perspectives.

Authors:  Shuo Wang; Chuanbin Mao; Shanrong Liu
Journal:  Signal Transduct Target Ther       Date:  2019-12-13

Review 2.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

3.  Estradiol shows anti-skin cancer activities through decreasing MDM2 expression.

Authors:  Li Li; Jianguo Feng; Ying Chen; Shun Li; Mengting Ou; Weichao Sun; Liling Tang
Journal:  Oncotarget       Date:  2017-01-31

4.  Alternative Splicing of SMAD4 and Its Function in HaCaT Cells in Response to UVB Irradiation.

Authors:  Irfan Ullah; Yi Liao; Rongxue Wan; Liling Tang; Jianguo Feng
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207

Review 5.  Peptides encoded by noncoding genes: challenges and perspectives.

Authors:  Shuo Wang; Chuanbin Mao; Shanrong Liu
Journal:  Signal Transduct Target Ther       Date:  2019-12-13

6.  BAF57/SMARCE1 Interacting with Splicing Factor SRSF1 Regulates Mechanical Stress-Induced Alternative Splicing of Cyclin D1.

Authors:  Jianguo Feng; Xichao Xu; Xin Fan; Qian Yi; Liling Tang
Journal:  Genes (Basel)       Date:  2021-02-21       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.